APPLICATION
ANDA076619
TYPE
ANDA
ORIGINAL APPROVAL
2011-06-29
LATEST ACTION
2020-12-28
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
IFOSFAMIDEPrescription
IFOSFAMIDE 3GM/60ML (50MG/ML) · INJECTABLE · INJECTION
IFOSFAMIDEPrescription
IFOSFAMIDE 1GM/20ML (50MG/ML) · INJECTABLE · INJECTION
Approval history
2020-12-28Labeling · Supplement 7 · standardAP
2011-06-29OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.